Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Entourage Health Corp V.ENTG

Alternate Symbol(s):  ETRGF

Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of brands in the Canadian market, including its brand Color Cannabis, mainstream brand Saturday Cannabis, medical cannabis product brand Starseed Medicinal and its craft cannabis brand Syndicate Cannabis. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including oils, capsules, soft chews, topicals, beverages and vapes, for sale in both the medical and adult-use markets across Canada. Its elite adult-use product portfolio includes Color Cannabis, Saturday Cannabis and now Dime Bag and Syndicate, sold across eight provincial distribution agencies.


TSXV:ENTG - Post by User

Comment by Equitylongshorton Aug 12, 2020 4:31pm
207 Views
Post# 31400107

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:0 products available on ocs

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:0 products available on ocs The medical channel is direct to consumer. That distribution platform allows them to keep all the revenue availble without having to share/split with the different channel partners.

They are correctly concentrating on product flowthrough with starseed first.

Yes, post harvest activities need efficiency improvements and that is being addressed and fixed.

Those of you who keep complaining about we need a executive with CPG experience do not understand what is being built. 

If you don't understand how PBM's work in America, you should familiarize yourself. I have yet to read any constructive critic who has yet understood this. 
<< Previous
Bullboard Posts
Next >>